Prognostic biomarkers correlated with immune infiltration in non‐small cell lung cancer
F Xu, W Cui, C Liu, F Feng, R Liu, J Zhang… - FEBS Open …, 2023 - Wiley Online Library
Lung cancer is the leading cause of cancer‐related mortality in men and women globally.
Non‐small cell lung cancer (NSCLC) is the most prevalent subtype, accounting for 85–90 …
Non‐small cell lung cancer (NSCLC) is the most prevalent subtype, accounting for 85–90 …
Prognostic biomarkers correlated with immune infiltration in non‐small cell lung cancer.
F Xu, W Cui, C Liu, F Feng, R Liu, J Zhang… - FEBS Open …, 2023 - search.ebscohost.com
Lung cancer is the leading cause of cancer‐related mortality in men and women globally.
Non‐small cell lung cancer (NSCLC) is the most prevalent subtype, accounting for 85–90 …
Non‐small cell lung cancer (NSCLC) is the most prevalent subtype, accounting for 85–90 …
Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer
F Xu, W Cui, C Liu, F Feng, R Liu, J Zhang… - FEBS Open …, 2023 - search.proquest.com
Lung cancer is the leading cause of cancer-related mortality in men and women globally.
Non-small cell lung cancer (NSCLC) is the most prevalent subtype, accounting for 85–90 …
Non-small cell lung cancer (NSCLC) is the most prevalent subtype, accounting for 85–90 …
Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer
F Xu, WQ Cui, C Liu, F Feng, R Liu… - FEBS open …, 2023 - pubmed.ncbi.nlm.nih.gov
Lung cancer is the leading cause of cancer-related mortality in men and women globally.
Non-small cell lung cancer (NSCLC) is the most prevalent subtype, accounting for 85-90 …
Non-small cell lung cancer (NSCLC) is the most prevalent subtype, accounting for 85-90 …
Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer.
F Xu, WQ Cui, C Liu, F Feng, R Liu, J Zhang… - FEBS Open bio, 2022 - europepmc.org
Lung cancer is the leading cause of cancer-related mortality in men and women globally.
Non-small cell lung cancer (NSCLC) is the most prevalent subtype, accounting for 85-90 …
Non-small cell lung cancer (NSCLC) is the most prevalent subtype, accounting for 85-90 …
[HTML][HTML] Prognostic biomarkers correlated with immune infiltration in non‐small cell lung cancer
F Xu, W Cui, C Liu, F Feng, R Liu, J Zhang… - FEBS Open Bio, 2023 - ncbi.nlm.nih.gov
Lung cancer is the leading cause of cancer‐related mortality in men and women globally.
Non‐small cell lung cancer (NSCLC) is the most prevalent subtype, accounting for 85–90 …
Non‐small cell lung cancer (NSCLC) is the most prevalent subtype, accounting for 85–90 …
Prognostic biomarkers correlated with immune infiltration in non‐small cell lung cancer
F Xu, W Cui, C Liu, F Feng, R Liu, J Zhang, C Sun - 2023 - agris.fao.org
Lung cancer is the leading cause of cancer‐related mortality in men and women globally.
Non‐small cell lung cancer (NSCLC) is the most prevalent subtype, accounting for 85–90 …
Non‐small cell lung cancer (NSCLC) is the most prevalent subtype, accounting for 85–90 …
[引用][C] Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer
F Xu, W Cui, C Liu, F Feng, R Liu, J Zhang, C Sun - europepmc.org
Lung cancer is the leading cause of cancer-related mortality in men and women globally.
Non-small cell lung cancer (NSCLC) is the most prevalent subtype, accounting for 85–90 …
Non-small cell lung cancer (NSCLC) is the most prevalent subtype, accounting for 85–90 …